lamivudine has been researched along with Infections, Hepadnaviridae in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Hu, Q; Yang, DL; Zhang, XY; Zhang, ZH; Zhang, ZM | 1 |
| Cheng, YC; Tan, S; Ying, C | 1 |
| Dai, Z; Teng, Y; Wu, B; Xu, Y; Zhong, Y | 1 |
| Furman, P; Martin, P; Pichoud, C; Seignères, B; Trépo, C; Zoulim, F | 1 |
| Deng, X; Yang, Z; Zhang, F | 1 |
| Addison, WR; Fischer, KP; Joyce, MA; Tyrrell, DL; Walters, KA | 1 |
| Chen, XM; Du, XF; Liu, ZM; Yang, ZG | 1 |
| Deray, G; Izzedine, H; Massard, J; Poynard, T | 1 |
| Chi, H; Dahmen, U; Dirsch, O; Gerlich, WH; Glebe, D; He, L; Kemper, T; Lorenz, H; Lu, M; Roggendorf, M; Wen, Y; Xu, Y; Yao, X | 1 |
| Buronfosse, T; Chevallier, M; Cova, L; Pradat, P; Thermet, A; Trepo, C; Werle-Lapostolle, B; Zoulim, F | 1 |
| Civitico, G; Colledge, D; Locarnini, S; Shaw, T | 1 |
| Fukuda, I; Omata, M; Saisho, H; Tagawa, M; Tamura, S; Tomita, T; Yokosuka, O | 1 |
| Chen, Y; Guo, S; Huang, A; Qi, Z | 1 |
13 other study(ies) available for lamivudine and Infections, Hepadnaviridae
| Article | Year |
|---|---|
[Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Topics: Animals; Animals, Newborn; Disease Models, Animal; DNA, Viral; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Liver; Reverse Transcriptase Inhibitors; Viremia | 2008 |
Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.
Topics: Animals; Antiviral Agents; Benzodioxoles; Cell Line; DNA, Viral; Dose-Response Relationship, Drug; Drug Synergism; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Lamivudine; Lignans; Phthalazines; RNA, Viral; Viral Core Proteins; Virus Replication | 2010 |
Synthesis, stability and pharmacological evaluation of a novel codrug consisting of lamivudine and ursolic acid.
Topics: Animals; Antiviral Agents; Chemical and Drug Induced Liver Injury; Drug Combinations; Drug Stability; Ducks; Half-Life; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lamivudine; Lipase; Mice; Mice, Inbred ICR; Plasma; Prodrugs; Protective Agents; Random Allocation; Triterpenes; Ursolic Acid | 2012 |
Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Cytidine Triphosphate; Dioxolanes; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Gene Expression Regulation, Viral; Guanosine; Hepadnaviridae Infections; Hepatitis B virus; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Hepatocytes; Humans; Lamivudine; Liver Neoplasms; Mutation; Purine Nucleosides; Reverse Transcriptase Inhibitors; Thiophenes; Tumor Cells, Cultured | 2002 |
[Anti-virus effect of combination of attenuated measles virus with 3TC on duck hepatitis B model].
Topics: Animals; Antiviral Agents; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Male; Measles Vaccine; Random Allocation; Vaccines, Attenuated | 2001 |
Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.
Topics: Animals; Carboxypeptidases; Drug Resistance, Viral; Ducks; Hepadnaviridae Infections; Hepatitis B Surface Antigens; Hepatitis B Virus, Duck; Hepatocytes; Lamivudine; Virus Replication | 2004 |
[Combination of lamivudine with thymosin alpha1 in treatment of duck hepatitis B].
Topics: Animals; Animals, Newborn; Antiviral Agents; Cells, Cultured; Drug Therapy, Combination; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Hepatocytes; Lamivudine; Thymalfasin; Thymosin; Virus Replication | 2005 |
Lamivudine and HBV-associated nephropathy.
Topics: Child; Child, Preschool; DNA, Viral; Female; Glomerulonephritis, Membranous; Hepadnaviridae Infections; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome | 2006 |
Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Hepadnaviridae Infections; Lamivudine; Marmota; Plasmids; Vaccines, DNA | 2008 |
DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection.
Topics: Animals; DNA, Viral; Ducks; Follow-Up Studies; Hepadnaviridae Infections; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Immune Tolerance; Lamivudine; Liver; Vaccines, DNA; Viral Envelope Proteins; Viremia | 2008 |
In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cells, Cultured; Drug Interactions; Drug Therapy, Combination; Ducks; Guanine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Humans; Lamivudine; Liver; Organophosphonates; Virus Replication | 2000 |
Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
Topics: Animals; DNA, Viral; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Viral Core Proteins; Virus Replication | 2000 |
[Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Topics: 2-Aminopurine; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Ducks; Famciclovir; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Microbial Sensitivity Tests | 2001 |